BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 28148946)

  • 1. HIV: CRISPR screen identifies novel therapeutic targets.
    Crunkhorn S
    Nat Rev Drug Discov; 2017 Feb; 16(2):88. PubMed ID: 28148946
    [No Abstract]   [Full Text] [Related]  

  • 2. Picking the Survivor! CRISPR Reveals HIV Dependency Factors.
    Schott K; König R
    Trends Microbiol; 2017 Apr; 25(4):243-245. PubMed ID: 28233621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A genome-wide CRISPR screen identifies a restricted set of HIV host dependency factors.
    Park RJ; Wang T; Koundakjian D; Hultquist JF; Lamothe-Molina P; Monel B; Schumann K; Yu H; Krupzcak KM; Garcia-Beltran W; Piechocka-Trocha A; Krogan NJ; Marson A; Sabatini DM; Lander ES; Hacohen N; Walker BD
    Nat Genet; 2017 Feb; 49(2):193-203. PubMed ID: 27992415
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A new method in biotechnology].
    Hofmann-Aßmus M
    MMW Fortschr Med; 2015 Apr; 157(7):75. PubMed ID: 26012467
    [No Abstract]   [Full Text] [Related]  

  • 5. New research on using CRISPR/Cas9 to treat HIV.
    Harper KN
    AIDS; 2017 Feb; 31(4):N7. PubMed ID: 27755113
    [No Abstract]   [Full Text] [Related]  

  • 6. Finding host targets for HIV therapy.
    Tsui CK; Gupta A; Bassik MC
    Nat Genet; 2017 Jan; 49(2):175-176. PubMed ID: 28138150
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A CRISPR screen identifies a pathway required for paraquat-induced cell death.
    Reczek CR; Birsoy K; Kong H; Martínez-Reyes I; Wang T; Gao P; Sabatini DM; Chandel NS
    Nat Chem Biol; 2017 Dec; 13(12):1274-1279. PubMed ID: 29058724
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CRISPR-Cas9: a new and promising player in gene therapy.
    Xiao-Jie L; Hui-Ying X; Zun-Ping K; Jin-Lian C; Li-Juan J
    J Med Genet; 2015 May; 52(5):289-96. PubMed ID: 25713109
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Zinc-finger nucleases make the cut in HIV.
    Owens B
    Nat Rev Drug Discov; 2014 May; 13(5):321-2. PubMed ID: 24781537
    [No Abstract]   [Full Text] [Related]  

  • 10. CRISPR therapeutics push into human testing.
    Sheridan C
    Nat Biotechnol; 2017 Jan; 35(1):3-5. PubMed ID: 28072788
    [No Abstract]   [Full Text] [Related]  

  • 11. CRISPR technology for gene therapy.
    High K; Gregory PD; Gersbach C
    Nat Med; 2014 May; 20(5):476-7. PubMed ID: 24804755
    [No Abstract]   [Full Text] [Related]  

  • 12. Gene targeting technologies in rats: zinc finger nucleases, transcription activator-like effector nucleases, and clustered regularly interspaced short palindromic repeats.
    Mashimo T
    Dev Growth Differ; 2014 Jan; 56(1):46-52. PubMed ID: 24372523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exploiting HIV-1 tropism to target CD4
    Freen-van Heeren JJ
    Immunol Cell Biol; 2021 Aug; 99(7):677-679. PubMed ID: 34231252
    [No Abstract]   [Full Text] [Related]  

  • 14. Genetic screens and functional genomics using CRISPR/Cas9 technology.
    Hartenian E; Doench JG
    FEBS J; 2015 Apr; 282(8):1383-93. PubMed ID: 25728500
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A CRISPR Dropout Screen Identifies Genetic Vulnerabilities and Therapeutic Targets in Acute Myeloid Leukemia.
    Tzelepis K; Koike-Yusa H; De Braekeleer E; Li Y; Metzakopian E; Dovey OM; Mupo A; Grinkevich V; Li M; Mazan M; Gozdecka M; Ohnishi S; Cooper J; Patel M; McKerrell T; Chen B; Domingues AF; Gallipoli P; Teichmann S; Ponstingl H; McDermott U; Saez-Rodriguez J; Huntly BJP; Iorio F; Pina C; Vassiliou GS; Yusa K
    Cell Rep; 2016 Oct; 17(4):1193-1205. PubMed ID: 27760321
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The revolution of the CRISPR is underway].
    Gilgenkrantz H
    Med Sci (Paris); 2014 Dec; 30(12):1066-9. PubMed ID: 25537031
    [No Abstract]   [Full Text] [Related]  

  • 17. Gene Editing With CRISPR/Cas9 RNA-Directed Nuclease.
    Doetschman T; Georgieva T
    Circ Res; 2017 Mar; 120(5):876-894. PubMed ID: 28254804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The CRISPR/Cas9 System and the Possibility of Genomic Edition for Cardiology.
    Arend MC; Pereira JO; Markoski MM
    Arq Bras Cardiol; 2017 Jan; 108(1):81-83. PubMed ID: 28146210
    [No Abstract]   [Full Text] [Related]  

  • 19. Elucidating drug targets and mechanisms of action by genetic screens in mammalian cells.
    Kampmann M
    Chem Commun (Camb); 2017 Jun; 53(53):7162-7167. PubMed ID: 28487920
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Not Available].
    Nau JY
    Rev Med Suisse; 2016 Apr; 12(514):766-7. PubMed ID: 27263157
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.